Skip to main content
. Author manuscript; available in PMC: 2023 Mar 2.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2022 Sep 2;31(9):1769–1779. doi: 10.1158/1055-9965.EPI-22-0123

Table 1.

Number of TGCT cases and controls included for testing associations with SNPs in methylation-related genes by originating study, and for cases by histologic type, family history of TGCT, and history of cryptorchidism

Studies TGCT Cases Controls (N)
ALL (N) Seminoma histology (N) Non-seminomatous histology (N) Family history (N) Cryptorchidism (N)
GWAS-DENMARK 183 88 55 na na 363
GWAS-NCI 581 243 334 76 131 1,056
GWAS-UPENN 481 171 299 49 39 919
GWAS- NORWAY/SWEDEN 1,326 766 549 na na 6,687
GWAS-UK 986 410 410 136 56 4,945
TECAC STUDY 5,602 2,456 2,760 95 295 5,006
deCODE ICELAND 300 na na na na 151,991
UK BIOBANK 697 395 223 na na 8,716
Total 10,156 4,529 4,630 356 521 179,683

N: number of subjects

GWAS: genome-wide association study

na: information not available by TECAC study: cases not included in stratified / restricted analysis